Illness perceptions and burden of disease in fibromyalgia

References

• Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011;86(5):457–464.
   PubMed Web of Science ®Google Scholar
• Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016;20(4):25.
   PubMed Web of Science ®Google Scholar
• Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–453.
   PubMed Web of Science ®Google Scholar
• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.
   PubMed Web of Science ®Google Scholar
• Walitt B, Nahin RL, Katz RS, et al. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015;10(9):e0138024.
   PubMed Web of Science ®Google Scholar
• Smith HS, Barkin RL. Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Dis Mon. 2011;57(5):248–285.
   PubMed Web of Science ®Google Scholar
• Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010;10:102.
   PubMed Web of Science ®Google Scholar
• Liu Y, Qian C, Yang M. Treatment patterns associated with ACR-recommended medications in the management of fibromyalgia in the United States. J Manag Care Spec Pharm. 2016;22(3):263–271.
   PubMedGoogle Scholar
• McNett M, Goldenberg D, Schaefer C, et al. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin. 2011;27(3):673–683.
   PubMed Web of Science ®Google Scholar
• Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27(3):663–671.
   PubMed Web of Science ®Google Scholar
• Schaefer C, Chandran A, Hufstader M, et al. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011;9:71.
   PubMed Web of Science ®Google Scholar
• Hayes SM, Myhal GC, Thornton JF, et al. Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude. Pain Res Manag. 2010;15(6):385–391.
   PubMed Web of Science ®Google Scholar
• Wuytack F, Miller P. The lived experience of fibromyalgia in female patients, a phenomenological study. Chiropr Man Ther. 2011;19(1):22.
   PubMedGoogle Scholar
• White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50(1):13–24.
   PubMed Web of Science ®Google Scholar
• Hassett AL, Clauw DJ, Williams DA. Premature aging in fibromyalgia. Curr Aging Sci. 2015;8(2):178–185.
   PubMedGoogle Scholar
• Nahin RL, Stussman BJ, Herman PM. Out-of-pocket expenditures on complementary health approaches associated with painful health conditions in a nationally representative adult sample. J Pain. 2015;16(11):1147–1162.
   PubMed Web of Science ®Google Scholar
• Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015;49(2):100–151.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.
   PubMed Web of Science ®Google Scholar
• Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res. 2013;65(5):786–792.
   PubMed Web of Science ®Google Scholar
• Ghavidel-Parsa B, Bidari A, Amir MA, et al. The iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain. 2015;28(3):169–176.
   PubMedGoogle Scholar
• Berger A, Dukes E, Martin S, et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61(9):1498–1508.
   PubMed Web of Science ®Google Scholar
• Schaefer C, Mann R, Masters ET, et al. The comparative burden of chronic widespread pain and fibromyalgia in the United States. Pain Pract. 2016;16(5):565–579.
   PubMed Web of Science ®Google Scholar
• White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001;5(4):320–329.
   PubMedGoogle Scholar
• Raphael KG, Janal MN, Nayak S, et al. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006;124(1–2):117–125.
   PubMed Web of Science ®Google Scholar
• Masi AT, White KP, Pilcher JJ. Person-centered approach to care, teaching, and research in fibromyalgia syndrome: justification from biopsychosocial perspectives in populations. Semin Arthritis Rheum. 2002;32(2):71–93.
   PubMed Web of Science ®Google Scholar
• Suresh E. How to diagnose fibromyalgia. Br J Hosp Med. 2015;76(12):696–702.
   Web of Science ®Google Scholar
• Robinson RL, Kroenke K, Mease P, et al. Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med. 2012;13(10):1366–1376.
   PubMed Web of Science ®Google Scholar
• Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005 Aug;75:6–21.
   PubMedGoogle Scholar
• Buskila D, Atzeni F, Sarzi-Puttini P. Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev. 2008;8(1):41–43.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.
   PubMed Web of Science ®Google Scholar
• Vervoort VM, Vriezekolk JE, Olde Hartman TC, et al. Cost of illness and illness perceptions in patients with fibromyalgia. Clin Exp Rheumatol. 2016;34(suppl 96):S74–S82.
   Google Scholar
• Perrot S, Choy E, Petersel D, et al. Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC Health Serv Res. 2012;12:356.
   PubMed Web of Science ®Google Scholar
• Briones-Vozmediano E, Vives-Cases C, Ronda-Perez E, et al. Patients’ and professionals’ views on managing fibromyalgia. Pain Res Manag. 2013;18(1):19–24.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Gebke KB, Choy EH. Fibromyalgia: management strategies for primary care providers. International J Clin Pract. 2016;70(2):99–112.
   PubMed Web of Science ®Google Scholar
• Baek SH, Seok HY, Koo YS, et al. Lengthened cutaneous silent period in fibromyalgia suggesting central sensitization as a pathogenesis. PLoS One. 2016;11(2):e0149248.
   Google Scholar
• Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007 Jun;36(6):339–356.
   PubMed Web of Science ®Google Scholar
• Theoharides TC. Atopic conditions in search of pathogenesis and therapy. Clin Ther. 2013 May;35(5):544–547.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004 Mar;50(3):944–952.
   PubMed Web of Science ®Google Scholar
• Ablin JN, Buskila D. Update on the genetics of the fibromyalgia syndrome. Best Pract Res Clin Rheumatol. 2015 Feb;29(1):20–28.
   PubMed Web of Science ®Google Scholar
• Kato K, Sullivan PF, Evengard B, et al. A population-based twin study of functional somatic syndromes. Psychol Med. 2009 Mar;39(3):497–505.
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Fibromyalgia: a clinical review. Jama. 2014 Apr 16;311(15):1547–1555.
   PubMed Web of Science ®Google Scholar
• Jones GT. Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes. Curr Rheumatol Rev. 2016;12(2):140–153.
   PubMedGoogle Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160–172.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–610.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011;38(6):1113–1122.
   PubMed Web of Science ®Google Scholar
• Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115–126.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Sarzi-Puttini P, Girolimetti R, et al. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009;27(5 suppl 56):S67–S74.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Li T, et al. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol. 2010;37(2):296–304.
   PubMed Web of Science ®Google Scholar
• Luo X, Cappelleri JC, Chandran A. The burden of fibromyalgia: assessment of health status using the euroqol (EQ-5D) in patients with fbromyalgia relative to other chronic conditions. Health Outcomes Res Med. 2011;2(4):e203–e214.
   Google Scholar
• Porter-Moffitt S, Gatchel RJ, Robinson RC, et al. Biopsychosocial profiles of different pain diagnostic groups. J Pain. 2006;7(5):308–318.
   PubMed Web of Science ®Google Scholar
• Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fibromyalgia. J Psychosom Res. 2007;62(2):145–151.
   PubMed Web of Science ®Google Scholar
• Affleck G, Urrows S, Tennen H, et al. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996;68(2–3):363–368.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Crofford LJ, Mease PJ, et al. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008;73(1):114–120.
   PubMed Web of Science ®Google Scholar
• Armentor JL. Living with a contested, stigmatized illness: experiences of managing relationships among women with fibromyalgia. Qual Health Res. 2015. DOI:10.1177/1049732315620160
   PubMed Web of Science ®Google Scholar
• Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics. 2014;32(5):457–466.
   PubMed Web of Science ®Google Scholar
• Podolecki T, Podolecki A, Hrycek A. Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns. Pol Arch Med Wewn. 2009;119(3):157–161.
   PubMed Web of Science ®Google Scholar
• Gerardi MC, Batticciotto A, Talotta R, et al. Novel pharmaceutical options for treating fibromyalgia. Expert Rev Clin Pharmacol. 2016;1–7. DOI:10.1586/17512433.2016.1145052.
   PubMed Web of Science ®Google Scholar
• Skaer TL. Treatment recommendations for fibromyalgia. Int J Pharma Res Rev. 2016;5(4):19–28.
   Google Scholar
• Uceyler N, Sommer C, Walitt B, et al. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;10:CD010782.
   PubMed Web of Science ®Google Scholar
• Hauser W, Bernardy K, Uceyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin—a meta-analysis of randomized controlled trials. Pain. 2009;145(1–2):69–81.
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;7:CD008242.
   PubMed Web of Science ®Google Scholar
• Hauser W, Wolfe F, Tolle T, et al. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26(4):297–307.
   PubMed Web of Science ®Google Scholar
• Nantz E, Liu-Seifert H, Skljarevski V. Predictors of premature discontinuation of treatment in multiple disease states. Patient Prefer Adherence. 2009;3:31–43.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen SY, Wu N, et al. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine. Pain Pract. 2011;11(4):381–391.
   PubMed Web of Science ®Google Scholar
• Sun P, Peng X, Sun S, et al. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators. Pain Pract. 2014;14(1):22–31.
   PubMed Web of Science ®Google Scholar
• Clark P, Paiva ES, Ginovker A, et al. A patient and physician survey of fibromyalgia across Latin America and Europe. BMC Musculoskelet Disord. 2013;14:188.
   PubMed Web of Science ®Google Scholar
• Lauche R, Hauser W, Jung E, et al. Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey. Clin Exp Rheumatol. 2013;31(6 suppl 79):S34–S40.
   Google Scholar
• Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann N Y Acad Sci. 2016. annrheumdis-2016-209724 [pii]. DOI:10.1136/annrheumdis-2016-209724
   Web of Science ®Google Scholar
• Chandran A, Schaefer C, Ryan K, et al. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Spec Pharm. 2012;18(6):415–426.
   PubMed Web of Science ®Google Scholar
• Berger A, Sadosky A, Dukes EM, et al. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care. 2010;16(5 suppl):S126–S137.
   PubMed Web of Science ®Google Scholar
• White LA, Robinson RL, Yu AP, et al. Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia. J Pain. 2009;10(9):976–983.
   PubMed Web of Science ®Google Scholar
• Knight T, Schaefer C, Chandran A, et al. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171–180.
   PubMedGoogle Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar
• Lacasse A, Bourgault P, Choinière M. Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskelet. 2016;17:168.
   PubMed Web of Science ®Google Scholar
• van Eijk-Hustings Y, Kroese M, Creemes A, et al. Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial. Clin Rheumatol. 2016;35:1307–1315.
   PubMed Web of Science ®Google Scholar
• Luciano JV, Sabes-Figuera R, Cardeñosa E, et al. Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care an economic evaluation alongside a 12-month randomized controlled trial. Clin J Pain. 2013;29:702–711.
   PubMed Web of Science ®Google Scholar
• Luciano JV, D’Amico F, Cerdà-Lafont M, et al. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Res Ther. 2014;16:451.
   PubMed Web of Science ®Google Scholar
• Ornelas HA, Buzzo AR, García L, et al. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico. Rheumatol Clin. 2012;8(3):120–127.
   Google Scholar